These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28982978)

  • 21. Local Repressor AcrR Regulates AcrAB Efflux Pump Required for Biofilm Formation and Virulence in
    Subhadra B; Kim J; Kim DH; Woo K; Oh MH; Choi CH
    Front Cell Infect Microbiol; 2018; 8():270. PubMed ID: 30131944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The
    Weidensdorfer M; Ishikawa M; Hori K; Linke D; Djahanschiri B; Iruegas R; Ebersberger I; Riedel-Christ S; Enders G; Leukert L; Kraiczy P; Rothweiler F; Cinatl J; Berger J; Hipp K; Kempf VAJ; Göttig S
    Virulence; 2019 Dec; 10(1):68-81. PubMed ID: 31874074
    [No Abstract]   [Full Text] [Related]  

  • 23. Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness.
    Johnson TL; Waack U; Smith S; Mobley H; Sandkvist M
    J Bacteriol; 2015 Dec; 198(4):711-9. PubMed ID: 26668261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro.
    Vila-Farrés X; Ferrer-Navarro M; Callarisa AE; Martí S; Espinal P; Gupta S; Rolain JM; Giralt E; Vila J
    J Antimicrob Chemother; 2015 Nov; 70(11):2981-6. PubMed ID: 26311838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling extracellular protein signatures to enhance live attenuated vaccine development through type II secretion system disruption in Vibriomimicus.
    Feng Y; Yu Z; Zhao R; Qin Z; Geng Y; Chen D; Huang X; Ouyang P; Zuo Z; Guo H; Deng H; Huang C; Lai W
    Microb Pathog; 2023 Aug; 181():106215. PubMed ID: 37380063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chaperone PrsA2 regulates the secretion, stability, and folding of listeriolysin O during
    Agbavor C; Zimnicka A; Kumar A; George JL; Torres M; Prehna G; Alonzo F; Durrant JD; Freitag NE; Cahoon LA
    mBio; 2024 Jul; 15(7):e0074324. PubMed ID: 38809022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Secrets of Acinetobacter Secretion.
    Weber BS; Kinsella RL; Harding CM; Feldman MF
    Trends Microbiol; 2017 Jul; 25(7):532-545. PubMed ID: 28216293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between bacteremia caused by Acinetobacter pittii and Acinetobacter nosocomialis.
    Liu YM; Lee YT; Kuo SC; Chen TL; Liu CP; Liu CE
    J Microbiol Immunol Infect; 2017 Feb; 50(1):62-67. PubMed ID: 25735795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the docking site between a type III secretion system ATPase and a chaperone for effector cargo.
    Allison SE; Tuinema BR; Everson ES; Sugiman-Marangos S; Zhang K; Junop MS; Coombes BK
    J Biol Chem; 2014 Aug; 289(34):23734-44. PubMed ID: 25035427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signature motifs identify an Acinetobacter Cif virulence factor with epoxide hydrolase activity.
    Bahl CD; Hvorecny KL; Bridges AA; Ballok AE; Bomberger JM; Cady KC; O'Toole GA; Madden DR
    J Biol Chem; 2014 Mar; 289(11):7460-9. PubMed ID: 24474692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment.
    Larcher R; Pantel A; Arnaud E; Sotto A; Lavigne JP
    BMC Infect Dis; 2017 Jul; 17(1):477. PubMed ID: 28683724
    [